BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25412552)

  • 61. Using WHO-FRAX to describe fracture risk: experience in primary care.
    MacLean FR; Thomson SA; Gallacher SJ
    Scott Med J; 2012 Feb; 57(1):8-13. PubMed ID: 22179858
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Official Positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®).
    Leib ES; Saag KG; Adachi JD; Geusens PP; Binkley N; McCloskey EV; Hans DB;
    J Clin Densitom; 2011; 14(3):212-9. PubMed ID: 21810527
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of risk factors for referring post-menopausal women for bone densitometry. The INSTANT study.
    Roux C; Fardellone P; Lespessailles E; Cotté FE; Mercier F; Gaudin AF
    Joint Bone Spine; 2008 Dec; 75(6):702-7. PubMed ID: 18617431
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analytical Study of the Risk Factors Affecting the Fracture Risk in Rheumatoid arthritis Patients using FRAX Algorithm.
    Sharma M; Singh P; Joshi A
    J Assoc Physicians India; 2022 Dec; 69(12):11-12. PubMed ID: 35057596
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Muscle strength is associated with fracture risk obtained by fracture risk assessment tool (FRAX) in women with breast cancer.
    de Almeida Marques Bernabé R; de Souza Vieira M; Felício de Souza V; Gomes Fontana L; Albergaria BH; Marques-Rocha JL; Guandalini VR
    BMC Cancer; 2022 Nov; 22(1):1115. PubMed ID: 36320019
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predicting the Subsequent Contralateral Hip Fracture: Is FRAX the Answer?
    Lott A; Pflug EM; Parola R; Egol KA; Konda SR
    J Orthop Trauma; 2022 Dec; 36(12):599-603. PubMed ID: 36399671
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of osteoporosis in women with peripheral osteoporotic fractures after 50 years of age: a study of practices.
    Briançon D; de Gaudemar JB; Forestier R
    Joint Bone Spine; 2004 Mar; 71(2):128-30. PubMed ID: 15050196
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Divergent effects of obesity on fragility fractures.
    Caffarelli C; Alessi C; Nuti R; Gonnelli S
    Clin Interv Aging; 2014; 9():1629-36. PubMed ID: 25284996
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Development of Novel Osteoporosis Screening Methods Using FRAX].
    Yamamoto N; Tsuchiya H
    Yakugaku Zasshi; 2019; 139(1):35-38. PubMed ID: 30606925
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Assessment and intervention thresholds to detect cases at risk of osteoporosis and fragility fractures with FRAX® in a mexican population for the first level of healthcare].
    Clark P; Ramírez-Pérez E; Reyes-López A
    Gac Med Mex; 2016 Oct; 152(Suppl 2):22-31. PubMed ID: 27792713
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rheumatoid arthritis, corticosteroid therapy and hip fracture.
    Cooper C; Coupland C; Mitchell M
    Ann Rheum Dis; 1995 Jan; 54(1):49-52. PubMed ID: 7880122
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Diagnostic approach to osteoporosis].
    Dimai HP
    Wien Med Wochenschr; 2009 May; 159(9-10):241-6. PubMed ID: 19484207
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urinary incontinence: a minor risk factor for hip fractures in elderly women.
    Johansson C; Hellström L; Ekelund P; Milsom I
    Maturitas; 1996 Aug; 25(1):21-8. PubMed ID: 8887305
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Falling and perimenopausal women.
    Torgerson DJ; Garton MJ; Reid DM
    Age Ageing; 1993 Jan; 22(1):59-64. PubMed ID: 8438669
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of adverse weather on osteoporotic fractures in older people.
    Wig S; Kayan K
    J Am Geriatr Soc; 2007 Nov; 55(11):1884. PubMed ID: 17979905
    [No Abstract]   [Full Text] [Related]  

  • 76. Factors associated with the use of hormone replacement therapy among older women.
    Cornuz J; Krieg MA; Sandini L; Ruffieux C; Van Melle G; Burckhardt P; Büche D; Dambacher M; Hartl F; Häuselmann H; Lippuner K; Neff M; Pancaldi P; Rizzoli R; Tanzi F; Theiler R; Tyndall A; Wimpfheimer C;
    Age Ageing; 2003 Nov; 32(6):675-8. PubMed ID: 14600013
    [No Abstract]   [Full Text] [Related]  

  • 77. Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: project rationale and description.
    Adami S; Bianchi G; Brandi ML; Di Munno O; Frediani B; Gatti D; Giannini S; Girasole G; Minisola G; Minisola S; Nuti R; Pedrazzoni M; Rossini M; Varenna M
    Clin Exp Rheumatol; 2010; 28(4):561-70. PubMed ID: 20497630
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Use of the FRAX algorithm to calculate the fracture risk in women of a rural area].
    Gómez Navarro R
    Rev Esp Salud Publica; 2010; 84(3):321-30. PubMed ID: 20661530
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The treatment of osteopenia in Asian women: a new approach.
    Tufts G
    J Am Acad Nurse Pract; 2011 Aug; 23(8):434-42. PubMed ID: 21790837
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Utilization of FRAX at orthopedic clinics].
    Hagino H; Katagiri H; Ito Y
    Clin Calcium; 2009 Dec; 19(12):1735-41. PubMed ID: 19949264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.